UPDATE: Albany Molecular Research Shares Down Roughly 20% At $10.27, Fell As Much As 23.3% At Low On Disclosure That Bristol-Myers Squibb Has Canceled Development of Drug With Company
August 12, 2013 at 13:35 PM EDT
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
